Suven Life Sciences Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for treating sleep and cognitive disorders; and Ropanicant (SUVN-911), an Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is also developing Usmarapride (SUVN-D4010), a bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for treating cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for treating gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is based in Hyderabad, India. Suven Life Sciences Limited operates as a subsidiary of Jasti Property and Equity Holdings Private Limited.
Key Metrics
PE ratio
-
PB ratio
10.88
Dividend yield
-
Beta
0.22
Market cap
₹31.95B
Enterprise value
₹28.28B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 138 |
| Website | https://www.suven.com |
| Mailing address | 8-2-334, SDE Serene Chambers 6th Floor Road No.5, Avenue 7 Banjara Hills Hyderabad 500034 India |
| Phone / Fax | 91 40 2354 1142 / 91 40 2354 1152 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Suven Life Sciences Limited paid ₹- dividend and the ex-dividend date was 14 Feb 2019.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SUVEN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Suven Life Sciences Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Venkateswarlu Jasti M.Pharm. M.S. | CEO, MD & Executive Chairman | 76 | |
| Dr. N. V. S. Ramakrishna M.Sc, Ph.D. | President & Chief Scientific Officer | 63 | |
| Ms. Sudharani Jasti B.Sc. | Whole-Time Director | 71 | |
| Mr. M. Mohan Kumar C.M.A. | Chief Financial Officer | ||
| Ms. Sangeetha Laxmi Kandari | Company Secretary & Compliance Officer | ||
| Ms. Kalyani Jasti | President of US Operations | 46 |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-3727.57%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Suven Life Sciences Limited is 31.95B and its enterprise value is 28.28B. The enterprise value to revenue ratio of SUVEN is 400.47. The enterprise value to EBITDA ratio of SUVEN is -10.18.
The SUVEN's stocks Beta value is 0.22 making it 78% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Suven Life Sciences Limited (NSE:SUVEN) Frequently Asked Questions
1. What is Suven Life Sciences Limited's Stock Symbol?
Suven Life Sciences Limited trades on NSE under the ticker symbol "SUVEN".
2. What is Suven Life Sciences Limited's stock price today?
One share of SUVEN stock can currently be purchased for approximately ₹137.74.
3. How can I contact Suven Life Sciences Limited?
Suven Life Sciences Limited's mailing address is 8-2-334, SDE Serene Chambers 6th Floor Road No.5, Avenue 7 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 2354 1142.
4. What is Suven Life Sciences Limited's official website?
The official website of Suven Life Sciences Limited is https://www.suven.com.